Advertisement
Case report| Volume 27, ISSUE 9, P1045-1052, May 01, 1990

Download started.

Ok

Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality

DOI:https://doi.org/10.1016/0006-3223(90)90040-9
Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality
Previous ArticleDeficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
Next ArticleElectrocardiographic effects of amitriptyline in therapeutic doses on 24-hr monitoring (Holter) with correlation to plasma levels
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ballenger J.C.
        • Post R.M.
        Carbamazepine in manic-depressive illness: A new treatment.
        Am J Psychiatry. 1980; 137: 782-790
        • Barkin R.
        • Braun B.G.
        • Kluft R.P.
        The dilemma of drug therapy for multiple personality disorder.
        in: Braun B.G. Treatment of Multiple Personality Disorder. American Psychiatric Press, Inc, Washington, DC1986: 107-132
        • Benson D.F.
        • Miller M.L.
        • Signer S.F.
        Dual personality associated with epilepsy.
        Arch Neurol. 1986; 43: 471-474
        • Bernstein J.G.
        Handbook of Drug Therapy in Psychiatry. PSG Publishing Co, Inc, Littleton, Massachusetts1988: 207-251
        • Boutros N.N.
        • Hughes J.R.
        • Weiler M.
        Psychiatric correlates of rhythmic midtemporal discharges and 6/sec spike and wave complexes.
        Biol Psychiatry. 1986; 21: 94-99
        • Braun B.G.
        Towards a theory of multiple personality and other dissociative phenomena.
        Psychiatr Clin North Am. 1984; 7: 171-193
        • Braun B.G.
        Treatment of Multiple Personality Disorder.
        American Psychiatric Press, Inc, Washington, DC1986
        • Coons P.M.
        The differential diagnosis of multiple personality: A comprehensive review.
        Psychiatr Clin North Am. 1984; 7: 51-68
        • Coons P.M.
        • Bowman E.S.
        • Milstein V.
        Multiple personality disorder: A clinical investigation of 50 cases.
        J Nerv Ment Dis. 1988; 176: 519-527
        • Coons P.M.
        • Milstein V.
        • Marley C.
        EEG studies of two multiple personalities and a control.
        Arch Gen Psychiatry. 1982; 39: 823-825
        • Cowdry R.W.
        • Gardner D.L.
        Pharmacotherapy of borderline personality disorder.
        Arch Gen Psychiatry. 1988; 45: 111-119
        • Dalby M.A.
        Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy.
        Epilepsia. 1971; 12: 325-334
        • Drake M.E.
        Epilepsy and multiple personality: Clinical and EEG findings in 15 cases.
        Epilepsia. 1986; 27: 635
        • Gardner D.L.
        • Cowdry R.W.
        Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
        Am J Psychiatry. 1986; 143: 519-522
        • Garvin J.S.
        Psychomotor variant pattern.
        Dis Nerv Syst. 1968; 29: 307-309
        • Gibbs F.A.
        • Gibbs E.L.
        Atlas of Electroencephalography. Vol. II. Addison-Wesley, Cambridge, Massachusetts1952: 356-374
        • Gibbs F.A.
        • Rich C.L.
        Psychomotor variant type of seizure discharge.
        Neurology. 1963; 13: 991-998
        • Hakola H.P.A.
        • Laulumaa V.A.
        Carbamazepine in treatment of violent schizophrenics.
        Lancet. 1982; i: 1358
        • Heber S.
        • Ross C.A.
        • Anderson G.
        • et al.
        Differentiating multiple personality disorder and partial complex seizures.
        in: Braun B.G. Proc 5th Int Conf on Multiple Personality/Dissociative States. Rush-Presbyterian-St. Luke's Medical Center, Chicago1988: 115
        • Horevitz R.P.
        • Braun B.G.
        Are multiple personalities borderline? An analysis of 33 cases.
        Psychiatr Clin North Am. 1984; 7: 69-87
        • Hughes J.R.
        • Cayaffa J.J.
        Is the “psychomotor variant”—“rhythmic mid-temporal discharge” an ictal pattern?.
        Clin Electroencephalogr. 1973; 4: 42-49
        • Hughes J.R.
        • Hermann B.P.
        Evidence for psychopathology in patients with rhythmic midtemporal discharges.
        Biol Psychiatry. 1984; 19: 1623-1634
        • Hughes J.R.
        • Wilson W.P.
        EEG and Evoked Potentials in Psychiatry and Behavioral Neurology.
        in: Butterworths, Boston1983: 295-346
        • Kluft R.P.
        Aspects of the treatment of multiple personality disorder.
        Psychiatric Ann. 1984; 14: 51-55
        • Kluft R.P.
        An update on multiple personality disorder.
        Hosp Community Psychiatry. 1987; 38: 363-373
        • Lerer B.
        • Moore N.
        • Meyendorff E.
        • Cho S.R.
        • Gershon S.
        Carbamazepine versus lithium in mania: A double-blind study.
        J Clin Psychiatry. 1987; 48: 89-93
        • Lipman I.J.
        • Hughes J.R.
        Rhythmic mid-temporal discharges: An electro-clinical study.
        Electroencephalogr Clin Neurophysiol. 1969; 27: 43-47
        • Lipper S.
        • Hammett E.G.
        • Davidson J.R.T.
        • et al.
        Preliminary study of carbamazepine in post-traumatic stress disorder.
        Psychosomatics. 1986; 27: 849-854
        • Luchins D.J.
        Carbamazepine for the violent psychiatric patient.
        Lancet. 1983; i: 766
        • Luchins D.J.
        Carbamazepine in violent non-epileptic schizophrenics.
        Psychopharmacol Bull. 1984; 20: 569-571
        • Marjerrison G.
        • Jedlicki S.M.
        • Keogh R.P.
        • Hrychuk W.
        • Poulakakis G.M.
        Carbamazepine: Behavioral, anticonvulsant and EEG effects in chronically hospitalized epileptics.
        Dis Nerv Syst. 1968; 29: 133-136
        • Mattes J.A.
        Carbamazepine for uncontrolled rage outbursts.
        Lancet. 1984; ii: 1164-1165
        • Mattes J.A.
        • Rosenberg J.
        • Mays D.
        Carbamazepine versus propranolol in patients with uncontrolled rage outbursts: A random assignment study.
        Psychopharmacol Bull. 1984; 20: 98-100
        • Mesulam M.M.
        Dissociative states with abnormal temporal lobe EEG: Multiple personality and the illusion of possession.
        Arch Neurol. 1981; 38: 176-181
        • Neppe V.M.
        Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities.
        J Clin Psychiatry. 1983; 44: 326-331
        • Okuma T.
        • Inanaga K.
        • Otsuki S.
        • et al.
        Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study.
        Psychopharmacology. 1979; 66: 211-217
        • Placidi G.F.
        • Lenzi A.
        • Lazzerini F.
        • Cassano G.B.
        • Akiskal H.S.
        The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients.
        J Clin Psychiatry. 1986; 47: 490-494
        • Post R.M.
        • Uhde T.W.
        • Putnam F.W.
        • Ballenger J.C.
        • Berrettini W.H.
        Kindling and carbamazepine in affective illness.
        J Nerv Ment Dis. 1982; 170: 717-731
        • Post R.M.
        • Uhde T.W.
        • Roy-Byrne P.P.
        • Joffee R.T.
        Correlates of antimanic response to carbamazepine.
        Psychiatry Res. 1987; 21: 71-83
        • Post R.M.
        • Trimble M.R.
        • Pippenger C.E.
        Clinical Use of Anticonvulsants in Psychiatric Disorders.
        Demos Publications, New York1989
        • Putnam F.W.
        The psychophysiologic investigation of multiple personality disorder. A review.
        Psychiatr Clin North Am. 1984; 7: 31-39
        • Putnam F.W.
        • Guroff J.J.
        • Silberman E.K.
        • Barban L.
        • Post R.M.
        The clinical phenomenology of multiple personality disorder. Review of 100 recent cases.
        J Clin Psychiatry. 1986; 47: 285-293
        • Rajotte P.
        • Jilek W.
        • Jilek L.
        • et al.
        Antiepileptic l and psychotropic properties of carbamazepine (Tegrotol).
        Union Med Can. 1967; 96: 1200-1206
        • Schenk L.
        • Bear D.
        Multiple personality and related dissociative phenomena in patients with temporal lobe epilepsy.
        Am J Psychiatry. 1981; 138: 1311-1316
        • Sheard M.H.
        Clinical pharmacology of aggressive behavior.
        Clin Neuropharmacol. 1984; 7: 173-183
        • Spiegel D.
        Multiple personality as a post-traumatic stress disorder.
        Psychiatr Clin North Am. 1984; 7: 101-110
        • Stone J.L.
        • McDaniel K.D.
        • Hughes J.R.
        • Herman B.P.
        Episodic dyscontrol disorder and paroxysmal EEG abnormalities: Successful treatment with carbamazepine.
        Biol Psychiatry. 1986; 21: 208-212
        • Tunks E.R.
        • Dermer S.W.
        Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction.
        J Nerv Ment Dis. 1977; 164: 56-63
        • Yassa R.
        • Dupont D.
        Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: A case report.
        Can J Psychiatry. 1983; 28: 566-568

      Article info

      Publication history

      Received in revised form: October 6, 1989
      Received: August 15, 1989

      Identification

      DOI: https://doi.org/10.1016/0006-3223(90)90040-9

      Copyright

      © 1990 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX